http://www.inboxrobot.com/news/chronic-lymphocytic-leukemiaConstantly updated news and information about a variety of topics. http://www.inboxrobot.com/news.php?fid=179857680 23 Jul 2008 12:50 GMT ... also reflects growing first-line use of Campath in the treatment of patients with B-cell chronic lymphocytic leukemia. Genzyme took a number of major steps during the second quarter to create opportunities ... http://www.inboxrobot.com/news.php?fid=179512039 21 Jul 2008 14:16 GMT ... United States. In January a major phase III trial in the first-line treatment of chronic lymphocytic leukemia showed that MabThera/Rituxan in combination with chemotherapy significantly increased progression-free survival (the time patients ... http://www.inboxrobot.com/news.php?fid=179508979 21 Jul 2008 13:52 GMT ... be used to treat other types of B-cell cancers, such as Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma. Biovest International, Inc. (OTCBB:BVTI) is a pioneer in the development of ... http://www.inboxrobot.com/news.php?fid=179498088 21 Jul 2008 12:30 GMT ... United States. In January a major phase III trial in the first-line treatment of chronic lymphocytic leukemia showed that MabThera/Rituxan in combination with chemotherapy significantly increased progression-free survival (the time patients ... http://www.inboxrobot.com/news.php?fid=179497838 21 Jul 2008 12:30 GMT ... be used to treat other types of B-cell cancers, such as Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma. ) is a pioneer in the development of advanced individualized immunotherapies ... http://www.inboxrobot.com/news.php?fid=179497610 21 Jul 2008 12:30 GMT ... United States. In January a major phase III trial in the first-line treatment of chronic lymphocytic leukemia showed that MabThera/Rituxan in combination with chemotherapy significantly increased progression-free survival (the time patients ...